Goldman Defends Intuitive Surgical

Intuitive Surgical’s stock is tanking, but Goldman Sachs says don’t panic — they’re sticking with a “Buy” rating and a $558 price target. The market’s overreacting to recent updates on the da Vinci 5 system, confusing instrument upgrades that boost hospital usage with changes that could impact revenue. Goldman clarifies that while some tweaks affect accessory sales, the core business remains strong, with 23% revenue growth and rising procedures. The real test? July’s earnings call, where more details will emerge — and where investors can decide if the sell-off is justified or just fear-driven. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/fe0da705b21ae46d